ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $172,000 | -63.2% | 60,077 | -1.4% | 0.00% | – |
| Q2 2019 | $467,000 | -39.7% | 60,943 | +4.7% | 0.00% | -100.0% |
| Q1 2019 | $774,000 | -37.2% | 58,222 | -26.3% | 0.00% | 0.0% |
| Q4 2018 | $1,232,000 | -19.2% | 79,050 | +1.9% | 0.00% | 0.0% |
| Q3 2018 | $1,525,000 | -28.0% | 77,584 | +5.2% | 0.00% | -50.0% |
| Q2 2018 | $2,118,000 | +8.7% | 73,784 | -10.5% | 0.00% | 0.0% |
| Q1 2018 | $1,949,000 | +1.5% | 82,406 | -8.1% | 0.00% | 0.0% |
| Q4 2017 | $1,921,000 | -20.9% | 89,633 | -12.7% | 0.00% | 0.0% |
| Q3 2017 | $2,428,000 | +5.2% | 102,631 | -12.3% | 0.00% | 0.0% |
| Q2 2017 | $2,307,000 | -30.6% | 117,060 | -26.0% | 0.00% | -33.3% |
| Q1 2017 | $3,323,000 | +26.4% | 158,226 | +13.2% | 0.00% | 0.0% |
| Q4 2016 | $2,629,000 | +28.1% | 139,809 | +42.3% | 0.00% | +50.0% |
| Q3 2016 | $2,053,000 | -39.0% | 98,284 | -25.5% | 0.00% | -50.0% |
| Q2 2016 | $3,364,000 | +44.0% | 131,888 | +49.4% | 0.00% | +33.3% |
| Q1 2016 | $2,336,000 | -9.9% | 88,280 | +45.7% | 0.00% | 0.0% |
| Q4 2015 | $2,592,000 | +17.7% | 60,590 | -27.1% | 0.00% | 0.0% |
| Q3 2015 | $2,203,000 | -40.3% | 83,088 | -25.0% | 0.00% | -25.0% |
| Q2 2015 | $3,691,000 | +68.5% | 110,764 | +68.4% | 0.00% | +100.0% |
| Q1 2015 | $2,190,000 | -29.8% | 65,793 | -13.8% | 0.00% | -33.3% |
| Q4 2014 | $3,119,000 | -12.5% | 76,321 | -27.4% | 0.00% | 0.0% |
| Q3 2014 | $3,563,000 | +35.9% | 105,159 | +35.3% | 0.00% | +50.0% |
| Q2 2014 | $2,621,000 | +68.9% | 77,740 | +90.0% | 0.00% | 0.0% |
| Q1 2014 | $1,552,000 | -71.8% | 40,914 | -78.3% | 0.00% | -60.0% |
| Q4 2013 | $5,505,000 | +199.3% | 188,504 | +250.6% | 0.01% | +150.0% |
| Q3 2013 | $1,839,000 | +79.9% | 53,767 | +73.5% | 0.00% | +100.0% |
| Q2 2013 | $1,022,000 | -60.2% | 30,986 | -61.4% | 0.00% | -66.7% |
| Q1 2013 | $2,570,000 | – | 80,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
| ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
| SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
| Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
| ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
| Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
| Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |